Fecal transplantation beyond C difficile

Fecal transplantation beyond C difficile

Dr Paul Moayyedi is a professor in the Division of Gastroenterology at McMaster University, Richard Hunt/AstraZeneca Chair in Gastroenterology, and the inaugural assistant dean of research.

See also

Indications for fecal microbiota transplantation Is fecal microbiota transplantation (FMT) going to be performed for indications other than Clostridium difficile infection (eg, alcoholic steatohepatitis, obesity, inflammatory bowel disease [IBD])?
Gut microbiota and diseases Can the gut microbiota lead to diseases (eg, cirrhosis or obesity)?
Reinvigorating the bedside clinical examination A lecture by Dr Brian Garibaldi, from Johns Hopkins Medicine, USA, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
Diagnosis and management of increased ferritin A lecture by Dr Mark Crowther, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
Maintaining the normal composition of the gut microbiota How to maintain the normal composition of the gut microbiota?
Management of GERD and Barrett esophagus A lecture by Dr Janusz Jankowski, from the Royal College of Surgeons in Ireland, Ireland, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.
How to manage incidental pancreatic cysts in an evidence-based era A lecture by Dr Paul Moayyedi, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.

Fecal transplantation beyond C difficile

Social Media